Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 750 of 1294 entries
View as:

A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01028404 Org: User:
Start: 11/30/09 End: 06/30/10 Due: 06/30/11

Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity

Phase: N/A Priority: Normal
NCT ID: NCT05444153 Org: User:
Start: 10/06/22 End: 08/29/25 Due: 08/29/26

Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04588259 Org: User:
Start: 10/09/20 End: 08/05/22 Due: 08/05/23

A Research Study of How NNC0174-0833 Behaves in Chinese Volunteers Who Are Normal Weight, Overweight or With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT05254158 Org: User:
Start: 03/03/22 End: 09/07/22 Due: 09/07/23

Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography

Phase: N/A Priority: Normal
NCT ID: NCT01561924 Org: User:
Start: 11/30/05 End: 05/31/06 Due: 05/31/07

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT01502124 Org: User:
Start: 05/08/01 End: 03/05/03 Due: 03/05/04

Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01561417 Org: User:
Start: 04/30/06 End: 09/30/06 Due: 09/30/07

Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients

Phase: N/A Priority: Normal
NCT ID: NCT03179748 Org: User:
Start: 06/20/18 End: 06/16/21 Due: 06/16/22

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03661879 Org: User:
Start: 09/12/18 End: 10/09/19 Due: 10/09/20

Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00472953 Org: User:
Start: 05/15/07 End: 03/05/08 Due: 03/05/09

A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs

Phase: N/A Priority: Normal
NCT ID: NCT03078478 Org: User:
Start: 03/13/17 End: 03/04/19 Due: 03/04/20

A Study of How CagriSema Works on Appetite in People With Excess Body Weight

Phase: N/A Priority: Normal
NCT ID: NCT06267092 Org: User:
Start: 02/15/24 End: 12/22/25 Due: 12/22/26

A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06478563 Org: User:
Start: 06/27/24 End: 07/01/25 Due: 07/01/26

A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT07023029 Org: User:
Start: 06/09/25 End: 09/14/25 Due: 09/14/26

Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues

Phase: N/A Priority: Normal
NCT ID: NCT01585506 Org: User:
Start: 09/20/10 End: 12/20/10 Due: 12/20/11

A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India

Phase: N/A Priority: Normal
NCT ID: NCT02117622 Org: User:
Start: 07/24/15 End: 04/05/17 Due: 04/05/18

A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine

Phase: N/A Priority: Normal
NCT ID: NCT03888157 Org: User:
Start: 03/10/19 End: 10/21/20 Due: 10/21/21

Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03308721 Org: User:
Start: 10/16/17 End: 01/03/20 Due: 01/03/21

Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01467375 Org: User:
Start: 01/08/01 End: 10/22/04 Due: 10/22/05

First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03015207 Org: User:
Start: 01/06/17 End: 10/26/17 Due: 10/26/18

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00611884 Org: User:
Start: 01/31/08 End: 08/31/08 Due: 08/31/09

Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01045707 Org: User:
Start: 01/31/10 End: 10/31/10 Due: 10/31/11

Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT01109017 Org: User:
Start: 10/31/09 End: 12/31/14 Due: 12/31/15

A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a Week

Phase: N/A Priority: Normal
NCT ID: NCT03723772 Org: User:
Start: 11/29/18 End: 06/26/20 Due: 06/26/21

Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients

Phase: N/A Priority: Normal
NCT ID: NCT01288391 Org: User:
Start: 01/31/11 End: 07/31/11 Due: 07/31/12